These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3576671)

  • 1. Pharmacodynamics of cyclosporine-ketoconazole interaction in mice. Combined therapy potentiates cyclosporine immunosuppression and toxicity.
    Anderson JE; Morris RE; Blaschke TF
    Transplantation; 1987 Apr; 43(4):529-33. PubMed ID: 3576671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients.
    First MR; Schroeder TJ; Alexander JW; Stephens GW; Weiskittel P; Myre SA; Pesce AJ
    Transplantation; 1991 Feb; 51(2):365-70. PubMed ID: 1994529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole inhibits cyclosporine metabolism in vivo in mice.
    Anderson JE; Blaschke TF
    J Pharmacol Exp Ther; 1986 Mar; 236(3):671-4. PubMed ID: 3950868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoconazole potentiates cyclosporine immunosuppression and toxicity in mice.
    Anderson JE; Morris RE; Blaschke TF
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1267-8. PubMed ID: 3274315
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients.
    Schroeder TJ; Melvin DB; Clardy CW; Wadhwa NK; Myre SA; Reising JM; Wolf RK; Collins JA; Pesce AJ; First MR
    J Heart Transplant; 1987; 6(2):84-9. PubMed ID: 3305834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination of cyclosporin and ketoconazole in immunosuppression schemes in patients with transplanted kidney].
    Treĭvish VS; Shoĭkhet IN; Ankova EV
    Klin Med (Mosk); 1998; 76(1):40-2. PubMed ID: 9532915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine-ketoconazole combination offers promise in reducing antirejection therapy costs.
    Randall T
    JAMA; 1990 Jul; 264(4):430-1. PubMed ID: 2366269
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction.
    Ulrich B; Frey FJ; Speck RF; Frey BM
    J Pharmacol Exp Ther; 1992 Feb; 260(2):487-90. PubMed ID: 1738098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.
    D'mello A; Venkataramanan R; Satake M; Todo S; Takaya S; Ptachcinski RJ; Burckart GJ; Starzl TE
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):441-54. PubMed ID: 2781141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients.
    First MR; Schroeder TJ; Weiskittel P; Myre SA; Alexander JW; Pesce AJ
    Lancet; 1989 Nov; 2(8673):1198-201. PubMed ID: 2572912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a Candida albicans delayed-type hypersensitivity (DTH) model in female juvenile rats for use in immunotoxicity assessments.
    Collinge M; Thorn M; Peachee V; White K
    J Immunotoxicol; 2013; 10(4):341-8. PubMed ID: 23282408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoconazole and high-dose methylprednisolone predisposing to cyclosporine-induced seizures: report of 3 cases.
    Hwang WL; Gau JP; Young JH; Chia LG
    Acta Haematol; 1992; 88(2-3):139-41. PubMed ID: 1466196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine and ketoconazole.
    White DJ; Blatchford NR; Cauwenbergh G
    Transplantation; 1984 Feb; 37(2):214-15. PubMed ID: 6320510
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation.
    Butman SM; Wild JC; Nolan PE; Fagan TC; Finley PR; Hicks MJ; Mackie MJ; Copeland JG
    J Heart Lung Transplant; 1991; 10(3):351-8. PubMed ID: 1854763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of immunosuppression by substitution of fish oil for olive oil as a vehicle for cyclosporine.
    Kelley VE; Kirkman RL; Bastos M; Barrett LV; Strom TB
    Transplantation; 1989 Jul; 48(1):98-102. PubMed ID: 2665242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial.
    First MR; Schroeder TJ; Michael A; Hariharan S; Weiskittel P; Alexander JW
    Transplantation; 1993 May; 55(5):1000-4. PubMed ID: 8497871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporine on host defence.
    Tchervenkov JI; Diano E; Christou NV
    Can J Surg; 1985 Nov; 28(6):525-7. PubMed ID: 4063893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
    J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration.
    Dieperink H; Kemp E; Leyssac PP; Starklint H; Wanscher M; Nielsen J; Jørgensen KA; Faber V; Flachs H
    Clin Nephrol; 1986; 25 Suppl 1():S137-43. PubMed ID: 3708923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpectedly low immunocompetence in transplant patients on ketoconazole.
    Watanabe T; Gao ZH; Shinozuka N; Schulick RD; Kuo A; Burdick JF
    Clin Transplant; 1997 Dec; 11(6):599-603. PubMed ID: 9408692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.